Some drugs, such as rapamycin, capivasertib, and bafilomycin, disrupt the activity of the mTOR signaling pathway and effectively inhibit viral infection and replication, suggesting that mTOR-related molecules are potential targets for anti-orthoflavivirus drug development. Here, MTOR is linked to viral infectious disease.